1. Greer LF 3rd, Szalay AA. Imaging of light emission from the expression of luciferases in living cells and organisms: a review. Luminescence 2002;17:43-74.
2. Blasberg RG. Plenary session II: Identifying biological targets and pathways for in vivo molecular imaging. First annual meeting of the society for molecular imaging 2002;USA: Boston.
3. Massoud TF, Gambhir SS. Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev 2003;17:545-580.
4. Contag CH, Spilman SD, Contag PR, Oshiro M, Eames B, Benaron DA, et al. Visualizing gene expression in living mammals using a bioluminescent reporter. Photochem Photobiol 1997;66:523-531.
5. Weissleder R, Mahmood U. Molecular imaging. Radiology 2001;219:316-333.
6. Lippincott-Schwartz J, Snapp E, Kenworthy A. Studying protein dynamics in living cells. Nat Rev Mol Cell Biol 2001;2:444-456.
7. Tung CH, Zeng Q, Shah K, Kim DE, Schellingerhout D, Weissleder R. In vivo imaging of beta-galactosidase activity using far red fluorescent switch. Cancer Res 2004;In press.
8. Luker GD, Luker KE, Sharma V, Pica CM, Dahlheimer JL, Piwnica-Worms D, et al. In vitro and in vivo characterization of a dual-function green fluorescent protein-HSV1-thymidine kinase reporter gene driven by the human elongation factor 1 alpha promoter. Mol Imaging 2002;1:65-73.
9. Josephson L, Kircher MF, Mahmood U, Tang Y, Weissleder R. Near-infrared fluorescent nanoparticles as combined MR/optical imaging probes. Bioconjug Chem 2002;13:554-560.
10. Weissleder R. A clearer vision for in vivo imaging. Nat Biotechnol 2001;19:316-317.
11. Moon WK, Lin Y, O'Loughlin T, Tang Y, Kim DE, Weissleder R, Tung CH. Enhanced tumor detection using a folate receptor-targeted near-infrared fluorochrome conjugate. Bioconjug Chem 2003;14:539-545.
12. Ntziachristos V, Tung CH, Bremer C, Weissleder R. Fluorescence molecular tomography resolves protease activity in vivo. Nat Med 2002;8:757-760.
13. Ntziachristos V, Chance B. Probing physiology and molecular function using optical imaging:applications to breast cancer. Breast Cancer Res 2001;3:41-46.
14. Tung CH, Mahmood U, Bredow S, Weissleder R. In vivo imaging of proteolytic enzyme activity using a novel molecular reporter. Cancer Res 2000;60:4953-4958.
15. Bremer C, Tung CH, Weissleder R. In vivo molecular target assessment of matrix metalloproteinase inhibition. Nat Med 2001;7:743-748.
16. Kircher MF, Mahmood U, King RS, Weissleder R, Josephson L. A multimodal nanoparticle for preoperative magnetic resonance imaging and intraoperative optical brain tumor delineation. Cancer Res 2003;63:8122-8125.
17. Detter C, Russ D, Iffland A, Wipper S, Schurr MO, Reichart B, et al. Near-infrared fluorescence coronary angiography: a new noninvasive technology for intraoperative graft patency control. Heart Surg Forum 2002;5:364-369.
18. Shah K, Tang Y, Breakefield X, Weissleder R. Real-time imaging of TRAIL-induced apoptosis of glioma tumors in vivo. Oncogene 2003;22:6865-6872.
19. Kim DE, Ishii K, Shah K, Weissleder R, Schellingerhout D. Imaging of stem cell recruitment to ischemic infarcts in a murine model. Stroke 2004;in press.
20. Shah K, Bureau E, Tang Y, Kim DE, Weissleder R, Breakefield X. Induction of apoptosis in glioma cells by novel TRAIL-secreting neural precursor cells (NPC) and in vivo tracking of NPC migration and tumor apoptosis. 33rd annual meeting of society for neuroscience 2003;New Orleans, USA: Abstract.
21. Fujimoto JG, Bouma B, Tearney GJ, Boppart SA, Pitris C, Brezinski ME, et al. New technology for high-speed and high-resolution optical coherence tomography. Ann N Y Acad Sci 1998;838:95-107.
22. Watanabe E, Yamashita Y, Maki A, Ito Y, Koizumi H. Non-invasive functional mapping with multi-channel near infrared spectroscopic topography in humans. Neurosci Lett 1996;205:41-44.
23. Kato H, Izumiyama M, Koizumi H, Takahashi A, Itoyama Y. Near-infrared spectroscopic topography as a tool to monitor motor reorganization after hemiparetic stroke: a comparison with functional MRI. Stroke 2002;33:2032-2036.